Farther Finance Advisors »

Protalix Biotherapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $253 108 2.34
2024-06-30 $98 85 1.16

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Dimensional International Value Etf Etf (DFIV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Vanguard Value Etf Etf (VTV)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Microsoft Corp Stock (MSFT)
Amazon Stock (AMZN)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)

View all positions for Farther Finance Advisors

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
State Street Corporation
Northern Trust
Geode Capital Management
Stratos Wealth Partners
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Susquehanna International
UBS Group

View all funds holding Protalix Biotherapeutics